MINI FUTURE LONG - DIASORIN Stock

DE000ME2KAU2

Market Closed - Börse Stuttgart 14:49:59 2024-06-20 EDT
3.95 ^EUR	+1.54%

Current month	-6.49%
1 month	-10.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Funds raise short on De Nora and Ariston.	06-18	AN
Funds move on BPM, DiaSorin and Iveco on the Mib.	06-17	AN
Millennium International moves on DiaSorin and Hera.	06-14	AN
Mib down; political instability weakens euro	06-14	AN

More news

Quotes 5-day view

Date	Price	Change
24-06-20	3.95	+1.54%
24-06-19	3.89	-4.42%
24-06-18	4.07	+2.26%
24-06-17	3.98	-0.75%
24-06-14	4.01	-7.18%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 02:49 pm

More quotes

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	Morgan Stanley
WKN	ME2KAU
ISIN	DE000ME2KAU2
Date issued	2023-10-25
Strike	57.66 €
Maturity	Unlimited
Parity	10 : 1
Emission price	2.79 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	4.52 €
Lowest since issue	2.56 €

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

97.32 EUR

Average target price

101.7 EUR

Spread / Average Target

+4.46%

Consensus